The limits of estimating COVID-19 intervention effects using Bayesian models
Bryant, P.; Elofsson, A.
Show abstract
To limit the rapid spread of COVID-19, most governments have introduced different non-pharmaceutical interventions, which might have severe costs for society. Therefore, it is crucial to evaluate the most cost-effective interventions, using, for instance, Bayesian modelling. Such modelling efforts have deemed lockdown to account for 81% of the reduction in R0, contributing to government policies. Here, we show that these conclusions are unsupported and that policies therefore should not be based on these studies. https://www.eurosurveillance.org/for-authors
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study 92%
- Evaluating the COVID-19 responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A counterfactual modelling study 92%
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 92%
Similar papers in this journal
- Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave 93%
- Significant Relaxation of SARS-CoV-2-Targeted Non-Pharmaceutical Interventions Will Result in Profound Mortality: A New York State Modelling Study 93%
- Bayesian uncertainty quantification to identify population level vaccine hesitancy behaviours 92%
Similar papers in this journal
- Estimating and Testing an Index of Bias Attributable to Composite Outcomes in Comparative Studies 91%
- Protocol for an observational study evaluating new approaches to modelling diagnostic information from large administrative hospital datasets 91%
- Information bias of vaccine effectiveness estimation due to informed consent for national registration of COVID-19 vaccination: estimation and correction using a data augmentation model 91%
Similar papers in this journal
- Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: Case study of COVID-19 in Alberta, Canada and Philadelphia, USA 94%
- Strengthening Policy Coding Methodologies to Improve COVID-19 Disease Modeling and Policy Responses: A Proposed Coding Framework and Recommendations 92%
- Over- and under-estimation of vaccine effectiveness 92%
Similar papers in this journal
- Predicting and forecasting the impact of local outbreaks of COVID-19: Use of SEIR-D quantitative epidemiological modelling for healthcare demand and capacity 91%
- Potential Test-Negative Design Study Bias in Outbreak Settings: Application to Ebola vaccination in Democratic Republic of Congo 91%
- A demographic scaling model for estimating the total number of COVID-19 infections 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.